{"title": "C\u00f3mo ganarle la guerra a la tuberculosis | by Melvin Sanicas - Project Syndicate", "author": "Melvin Sanicas", "url": "https://www.project-syndicate.org/commentary/eradicating-tuberculosis-by-melvin-sanicas-2016-04/spanish", "hostname": "project-syndicate.org", "description": "Project Syndicate - The World\u2019s Opinion Page", "sitename": "Project Syndicate", "date": "2016-04-04", "id": null, "license": null, "body": null, "comments": "SEATTLE \u2013 Los seres humanos han luchado contra la tuberculosis desde la Edad de Piedra. Pero reci\u00e9n en el siglo pasado se hizo un verdadero progreso contra la enfermedad. Una vacuna, utilizada por primera vez en seres humanos en 1921, hoy sigue en uso en todo el mundo. Y una serie de antibi\u00f3ticos, empezando por la estreptomicina en los a\u00f1os 1940, han demostrado ser efectivos en el tratamiento de las infecciones.\nDesde 1990, la tasa de mortalidad anual como consecuencia de la tuberculosis se ha reducido pr\u00e1cticamente a la mitad. De 2000 a 2014, mejores diagn\u00f3sticos y tratamientos salvaron unos 43 millones de vidas. Sin embargo, el progreso se ha vuelto extremadamente lento, lo que sugiere que la batalla est\u00e1 lejos de haber terminado. La ca\u00edda anual de los casos en los \u00faltimos diez a\u00f1os ha sido apenas del 1,65%; en 2014, la tuberculosis mat\u00f3 a 1,5 mill\u00f3n de personas.\nMientras tanto, hay cepas de la enfermedad que est\u00e1n desarrollando una resistencia al tratamiento. El mal uso y la mala administraci\u00f3n de los antibi\u00f3ticos han resultado en una tuberculosis resistente a m\u00faltiples drogas. Estas cepas se deben tratar con medicamentos de segunda l\u00ednea, que son m\u00e1s costosos y muchas veces causan peores efectos colaterales. Tambi\u00e9n aparecieron cepas que son resistentes a los f\u00e1rmacos de segunda l\u00ednea, conocidas como tuberculosis extremadamente resistente (XDR-TB por su sigla en ingl\u00e9s).\nTo continue reading, register now.\nSubscribe now for unlimited access to everything PS has to offer.\nSubscribe\nAs a registered user, you can enjoy more PS content every month \u2013 for free.\nRegister\nAlready have an account? Log in", "commentsbody": null, "raw_text": null, "text": "SEATTLE \u2013 Los seres humanos han luchado contra la tuberculosis desde la Edad de Piedra. Pero reci\u00e9n en el siglo pasado se hizo un verdadero progreso contra la enfermedad. Una vacuna, utilizada por primera vez en seres humanos en 1921, hoy sigue en uso en todo el mundo. Y una serie de antibi\u00f3ticos, empezando por la estreptomicina en los a\u00f1os 1940, han demostrado ser efectivos en el tratamiento de las infecciones.\nDesde 1990, la tasa de mortalidad anual como consecuencia de la tuberculosis se ha reducido pr\u00e1cticamente a la mitad. De 2000 a 2014, mejores diagn\u00f3sticos y tratamientos salvaron unos 43 millones de vidas. Sin embargo, el progreso se ha vuelto extremadamente lento, lo que sugiere que la batalla est\u00e1 lejos de haber terminado. La ca\u00edda anual de los casos en los \u00faltimos diez a\u00f1os ha sido apenas del 1,65%; en 2014, la tuberculosis mat\u00f3 a 1,5 mill\u00f3n de personas.\nMientras tanto, hay cepas de la enfermedad que est\u00e1n desarrollando una resistencia al tratamiento. El mal uso y la mala administraci\u00f3n de los antibi\u00f3ticos han resultado en una tuberculosis resistente a m\u00faltiples drogas. Estas cepas se deben tratar con medicamentos de segunda l\u00ednea, que son m\u00e1s costosos y muchas veces causan peores efectos colaterales. Tambi\u00e9n aparecieron cepas que son resistentes a los f\u00e1rmacos de segunda l\u00ednea, conocidas como tuberculosis extremadamente resistente (XDR-TB por su sigla en ingl\u00e9s).\nTo continue reading, register now.\nSubscribe now for unlimited access to everything PS has to offer.\nAccess every new PS commentary, our entire On Point suite of subscriber-exclusive content \u2013 including Longer Reads, Insider Interviews, Big Picture/Big Question, and Say More \u2013 and the full PS archive.\nTo prevent catastrophic climate change and accelerate the global transition to a net-zero economy, policymakers and asset owners urgently need to rethink how we channel capital at scale. The key is to develop new financial instruments that are profitable, liquid, and easily accessible to savers and investors globally.\nexplain what it will take to channel private capital and savings toward sustainable development.\nIt is no exaggeration to say that the GCF\u2019s replenishment campaign is a test of the world\u2019s commitment to combating global warming. A successful outcome would not only help close the massive global climate financing gap, but would also allow developed countries to rebuild trust by showing that they understand the urgency of the crisis.\nurge advanced economies to help developing countries by ensuring that the GCF has the resources it needs.", "language": null, "image": "https://webapi.project-syndicate.org/library/65fdc2da728de26658a8e336cb677933.2-1-large.1.jpg", "pagetype": "article", "links": ["#main", "/", "/newsletters", "/order/subscription?trigger=header&url=%2Fcommentary%2Fafrica-credit-rating-downgrades-hurt-economic-development-by-hippolyte-fofack-2021-08&redirect=%2Fcommentary%2Fafrica-credit-rating-downgrades-hurt-economic-development-by-hippolyte-fofack-2021-08", "/account/login", "/archive", "/section/economics", "/section/politics-world-affairs", "/onpoint", "/magazines", "/columnists", "/section/environment-sustainability", "/section/global-health-development", "/topic/the-ai-revolution", "/topic/the-russia-ukraine-crisis", "/section/culture-society", "/topic/the-african-century", "/topic/democracy-and-its-enemies", "/topic/finance-of-the-future", "/commentary/eradicating-tuberculosis-by-melvin-sanicas-2016-04/arabic", "/commentary/eradicating-tuberculosis-by-melvin-sanicas-2016-04/chinese", "/commentary/eradicating-tuberculosis-by-melvin-sanicas-2016-04/czech", "/commentary/eradicating-tuberculosis-by-melvin-sanicas-2016-04/dutch", "/commentary/eradicating-tuberculosis-by-melvin-sanicas-2016-04", "/commentary/eradicating-tuberculosis-by-melvin-sanicas-2016-04/french", "/commentary/eradicating-tuberculosis-by-melvin-sanicas-2016-04/german", "/commentary/eradicating-tuberculosis-by-melvin-sanicas-2016-04/indonesian", "/commentary/eradicating-tuberculosis-by-melvin-sanicas-2016-04/italian", "/commentary/eradicating-tuberculosis-by-melvin-sanicas-2016-04/russian", "/section/global-health-development", "https://www.facebook.com/sharer.php?u=https://www.project-syndicate.org/commentary/eradicating-tuberculosis-by-melvin-sanicas-2016-04/spanish", "https://twitter.com/intent/tweet?url=https%3A%2F%2Fprosyn.org%2FW8RiJhdes&text=C%C3%B3mo%20ganarle%20la%20guerra%20a%20la%20tuberculosis%20by%20Melvin%20Sanicas%20%40ProSyn", "https://www.linkedin.com/shareArticle?mini=true&url=https://prosyn.org/W8RiJhdes&title=C%C3%B3mo%20ganarle%20la%20guerra%20a%20la%20tuberculosis&summary=Project%20Syndicate%20-%20The%20World%E2%80%99s%20Opinion%20Page&source=Project%20Syndicate", "https://www.project-syndicate.org/commentary/eradicating-tuberculosis-by-melvin-sanicas-2016-04/spanish", "/columnist/melvin-sanicas", "/order/subscription?route=commentary&url=eradicating-tuberculosis-by-melvin-sanicas-2016-04&trigger=regwall&highlight=subscription&redirect=%2Fcommentary%2Feradicating-tuberculosis-by-melvin-sanicas-2016-04%2Fspanish%3Fbarrier%3Daccesspaylog", "/account/login?tab=tab-register&returnURL=%2Fcommentary%2Feradicating-tuberculosis-by-melvin-sanicas-2016-04%2Fspanish%3Fbarrier%3Daccesspaylog", "/account/login?returnURL=%2Fcommentary%2Feradicating-tuberculosis-by-melvin-sanicas-2016-04%2Fspanish%3Fbarrier%3Daccesspaylog", "https://www.project-syndicate.org/order/subscription?route=commentary&url=eradicating-tuberculosis-by-melvin-sanicas-2016-04&trigger=&redirect=%2Fcommentary%2Feradicating-tuberculosis-by-melvin-sanicas-2016-04", "/columnist/melvin-sanicas", "/columnist/melvin-sanicas", "#", "/profile/anansi-white", "/profile/kelly-sheldrick", "/profile/kendall-o-geil", "/profile/jamie-adair", "/profile/sara-jones", "/profile/juan-miguel-martinez", "/profile/rijal-kadakia", "/profile/alex-christopher", "https://www.project-syndicate.org/commentary/eradicating-tuberculosis-by-melvin-sanicas-2016-04/spanish", "whatsapp://send?text=C%C3%B3mo%20ganarle%20la%20guerra%20a%20la%20tuberculosis%20by%20Melvin%20Sanicas%20%40ProSyn%20https%3A%2F%2Fprosyn.org%2FW8RiJhdes", "javascript:if(window.print)window.print()", "https://www.facebook.com/sharer.php?u=https://www.project-syndicate.org/commentary/eradicating-tuberculosis-by-melvin-sanicas-2016-04/spanish", "https://twitter.com/intent/tweet?url=https%3A%2F%2Fprosyn.org%2FW8RiJhdes&text=C%C3%B3mo%20ganarle%20la%20guerra%20a%20la%20tuberculosis%20by%20Melvin%20Sanicas%20%40ProSyn", "https://www.linkedin.com/shareArticle?mini=true&url=https://prosyn.org/W8RiJhdes&title=C%C3%B3mo%20ganarle%20la%20guerra%20a%20la%20tuberculosis&summary=Project%20Syndicate%20-%20The%20World%E2%80%99s%20Opinion%20Page&source=Project%20Syndicate", "/profile/me", "/member/editnewsletterpreferences?hash=", "/commentary/local-media-key-to-democracy-how-to-protect-it-by-laura-tyson-and-lenny-mendonca-2023-09", "/section/culture-society", "/commentary/local-media-key-to-democracy-how-to-protect-it-by-laura-tyson-and-lenny-mendonca-2023-09#comments", "/commentary/local-media-key-to-democracy-how-to-protect-it-by-laura-tyson-and-lenny-mendonca-2023-09", "/columnist/laura-tyson", "/columnist/lenny-mendonca", "/columnist/anya-schiffrin", "/commentary/local-news-media-pandemic-support-by-anya-schiffrin-2021-02", "/commentary/un-high-level-meeting-on-universal-health-coverage-comprehensive-cancer-care-by-sonali-johnson-2023-09", "/section/global-health-development", "/commentary/un-high-level-meeting-on-universal-health-coverage-comprehensive-cancer-care-by-sonali-johnson-2023-09#comments", "/commentary/un-high-level-meeting-on-universal-health-coverage-comprehensive-cancer-care-by-sonali-johnson-2023-09", "/columnist/sonali-johnson", "/columnist/miriam-mutebi", "/commentary/cancer-crisis-in-africa-needs-investment-in-testing-and-prevention-by-miriam-mutebi-2023-03", "/commentary/climate-finance-private-capital-new-financial-instruments-by-nouriel-roubini-and-reza-bundy-2023-09", "/section/environment-sustainability", "/commentary/climate-finance-private-capital-new-financial-instruments-by-nouriel-roubini-and-reza-bundy-2023-09#comments", "/commentary/climate-finance-private-capital-new-financial-instruments-by-nouriel-roubini-and-reza-bundy-2023-09", "/columnist/nouriel-roubini", "/columnist/reza-bundy", "/columnist/mahmoud-mohieldin", "/commentary/africa-needs-more-climate-finance-by-mahmoud-mohieldin-et-al-2023-09", "/commentary/biden-economy-low-unemployment-inflation-falling-but-real-wages-lag-by-james-k-galbraith-2023-09", "/section/economics", "/commentary/biden-economy-low-unemployment-inflation-falling-but-real-wages-lag-by-james-k-galbraith-2023-09#comments", "/commentary/biden-economy-low-unemployment-inflation-falling-but-real-wages-lag-by-james-k-galbraith-2023-09", "/columnist/james-k-galbraith", "/columnist/barry-eichengreen", "/commentary/biden-popularity-lagging-strong-us-economy-by-barry-eichengreen-2023-08", "/commentary/why-us-dollar-hegemony-will-survive-by-carla-norrlof-2023-09", "/section/economics", "/commentary/why-us-dollar-hegemony-will-survive-by-carla-norrlof-2023-09#comments", "/commentary/why-us-dollar-hegemony-will-survive-by-carla-norrlof-2023-09", "/columnist/carla-norrlof", "/columnist/carla-norrlof", "/magazine/will-multipolarity-follow-global-dollar-hegemony-by-carla-norrlof-2023-06", "/commentary/developed-countries-must-fully-replenish-the-green-climate-fund-by-vera-songwe-and-mahmoud-mohieldin-2023-09", "/section/environment-sustainability", "/commentary/developed-countries-must-fully-replenish-the-green-climate-fund-by-vera-songwe-and-mahmoud-mohieldin-2023-09#comments", "/commentary/developed-countries-must-fully-replenish-the-green-climate-fund-by-vera-songwe-and-mahmoud-mohieldin-2023-09", "/columnist/vera-songwe", "/columnist/mahmoud-mohieldin", "/columnist/vera-songwe", "/magazine/financing-net-zero-green-transition-during-polycrisis-by-vera-songwe-2023-09", "/commentary/protectionism-helped-trigger-new-cold-war-geopolitical-conflict-by-pinelopi-koujianou-goldberg-2023-09", "/section/politics-world-affairs", "/commentary/protectionism-helped-trigger-new-cold-war-geopolitical-conflict-by-pinelopi-koujianou-goldberg-2023-09#comments", "/commentary/protectionism-helped-trigger-new-cold-war-geopolitical-conflict-by-pinelopi-koujianou-goldberg-2023-09", "/columnist/pinelopi-koujianou-goldberg", "/columnist/dani-rodrik", "/commentary/global-economy-biggest-risk-is-geopolitics-not-protectionism-by-dani-rodrik-2023-09", "/commentary/world-economy-needs-new-debt-restructuring-framework-by-anne-o-krueger-2023-09", "/section/economics", "/commentary/world-economy-needs-new-debt-restructuring-framework-by-anne-o-krueger-2023-09#comments", "/commentary/world-economy-needs-new-debt-restructuring-framework-by-anne-o-krueger-2023-09", "/columnist/anne-o-krueger", "/columnist/masood-ahmed-1", "/commentary/human-costs-of-african-countries-efforts-to-avoid-debt-default-by-masood-ahmed-1-2023-06", "/commentary/naomi-klein-new-book-unique-insights-into-current-politics-by-jeffrey-frankel-2023-09", "/section/politics-world-affairs", "/commentary/naomi-klein-new-book-unique-insights-into-current-politics-by-jeffrey-frankel-2023-09#comments", "/commentary/naomi-klein-new-book-unique-insights-into-current-politics-by-jeffrey-frankel-2023-09", "/columnist/jeffrey-frankel", "/columnist/susan-stokes", "/commentary/trump-indictment-breaking-through-self-defense-of-lies-by-susan-stokes-2023-06", "/order/subscription?trigger=footer", "/order/subscription?trigger=footer", "/donation?trigger=footer", "/member/editnewsletterpreferences?hash=", "https://www.facebook.com/projectsyndicate", "https://twitter.com/prosyn", "https://www.linkedin.com/company/project-syndicate", "https://www.youtube.com/user/ProjectSyndicate", "/magazines", "/sections", "/topics", "/archive", "/columnists", "/videos", "/podcasts", "/onpoint", "/longreads", "/insider-interview", "/say-more", "/bigpictures", "/global-bookmark", "/rewards", "/about", "/about?tab=contact-us", "/pages/careers", "/faq", "/pages/submission-guidelines", "/newsletters", "/member-publications", "https://syndication.project-syndicate.org", "https://magazines.project-syndicate.org", "https://events.project-syndicate.org", "/education", "/pages/privacy-policy", "/pages/terms-and-conditions", "/pages/cookie-policy", "https://www.flow.li", "/sections", "/archive", "/section/economics", "/section/politics-world-affairs", "/section/global-health-development", "/section/environment-sustainability", "/section/culture-society", "/section/innovation-technology", "/topics", "/columnists", "/videos", "/podcasts", "/onpoint", "/longreads", "/insider-interview", "/say-more", "/bigpictures", "/global-bookmark", "/magazines", "/faq", "/order/subscription?trigger=header", "/order/donation?trigger=header", "/rewards", "/about", "https://syndication.project-syndicate.org", "/member-publications", "https://twitter.com/prosyn", "https://www.facebook.com/projectsyndicate", "https://www.youtube.com/user/ProjectSyndicate", "https://www.linkedin.com/company/project-syndicate", "/pages/terms-and-conditions", "#facebook-login-register", "#microsoft-login-register", "#twitter-login-register"]}